BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19835834)

  • 1. Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation.
    Reed K; Poulin ML; Yan L; Parissenti AM
    Anal Biochem; 2010 Feb; 397(1):96-106. PubMed ID: 19835834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-molecule polymerase chain reaction reduces bias: application to DNA methylation analysis by bisulfite sequencing.
    Chhibber A; Schroeder BG
    Anal Biochem; 2008 Jun; 377(1):46-54. PubMed ID: 18358818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo quantitative bisulfite sequencing using the pyrosequencing technology.
    Dupont JM; Tost J; Jammes H; Gut IG
    Anal Biochem; 2004 Oct; 333(1):119-27. PubMed ID: 15351288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
    Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
    Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
    Reed K; Hembruff SL; Sprowl JA; Parissenti AM
    Pharmacogenomics J; 2010 Dec; 10(6):489-504. PubMed ID: 20125118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.
    Baker EK; El-Osta A
    Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure.
    Shiao YH; Crawford EB; Anderson LM; Patel P; Ko K
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):290-6. PubMed ID: 15922014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
    Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisulfite-modified target DNA array for aberrant methylation analysis.
    Zhou D; Qiao W; Yang L; Lu Z
    Anal Biochem; 2006 Apr; 351(1):26-35. PubMed ID: 16516134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF.
    Schatz P; Dietrich D; Schuster M
    Nucleic Acids Res; 2004 Dec; 32(21):e167. PubMed ID: 15576674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantification of differentially methylated loci by the pyrosequencing technology.
    Dejeux E; El abdalaoui H; Gut IG; Tost J
    Methods Mol Biol; 2009; 507():189-205. PubMed ID: 18987816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
    Qiu G; Fang J; He Y
    Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation analysis by bisulfite conversion, cloning, and sequencing of individual clones.
    Zhang Y; Rohde C; Tierling S; Stamerjohanns H; Reinhardt R; Walter J; Jeltsch A
    Methods Mol Biol; 2009; 507():177-87. PubMed ID: 18987815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods.
    Fuso A; Scarpa S; Grandoni F; Strom R; Lucarelli M
    Anal Biochem; 2006 Mar; 350(1):24-31. PubMed ID: 16445884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.